Go
All Publishers
24-7 Press Release Newswire
3BL Media
AccessWire
Brandpoint
Chainwire
Evertise Digital
EZ Newswire
GlobeNewswire
Get Featured
Investor Brand Network
iCrowdNewswire
IssueWire
KeyCrew
Prodigy Press Wire
KoreWire
Law Firm Newswire
Media OutReach
MoneyShow Newswire
NewsDirect
TheNewswire.com
NewsUSA
Newsworthy.ai
Pinion Newswire
PRWire360
Press Advantage
PR.com
PR Distribution
PRISM MarketView
PR Newswire
PRUnderground
FirstPublisher
Qwoted
RestaurantNews.com
Send2Press
Syndication Cloud
Press Services
Shan News Network
StatePoint Media
WebWire
Imperial Announces Voting Results for the Election of Directors
GlobeNewswire
Today at 9:02pm UTC
Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for...
GlobeNewswire
Today at 9:02pm UTC
Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid...
GlobeNewswire
Today at 9:01pm UTC
Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
GlobeNewswire
Today at 9:01pm UTC
ALDX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel...
GlobeNewswire
Today at 9:01pm UTC
Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated...
GlobeNewswire
Today at 9:01pm UTC
AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
GlobeNewswire
Today at 9:00pm UTC
Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
PR Newswire
Today at 9:00pm UTC
Legend Biotech Announces Presentations at ASCO 2026
GlobeNewswire
Today at 9:00pm UTC
Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
PR Newswire
Today at 9:00pm UTC
Navient declares second quarter common stock dividend
GlobeNewswire
Today at 9:00pm UTC
Sapience Therapeutics Provides Positive Data Update from Phase 2 Trial of Lucicebtide Plus SOC in Patients with Glioblastoma at the 2026...
PR Newswire
Today at 9:00pm UTC
Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
GlobeNewswire
Today at 9:00pm UTC
Greenberg Traurig Bolsters Government Contracts and Space Practices with Shaun Kennedy in Denver
PR Newswire
Today at 9:00pm UTC
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
GlobeNewswire
Today at 9:00pm UTC
Boehringer Ingelheim's oncology portfolio shows strong promise across multiple cancers at ASCO 2026
PR Newswire
Today at 9:00pm UTC
NVIDIA Announces Upcoming Events for Financial Community
GlobeNewswire
Today at 9:00pm UTC
Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology...
PR Newswire
Today at 9:00pm UTC
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post...
GlobeNewswire
Today at 9:00pm UTC
New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
PR Newswire
Today at 9:00pm UTC
<
1
2
3
4
5
6
...
19
20
>
Skip to main content
Our Newspapers
Ashland
Bellingham
Franklin
Holliston
Hopedale
Medway/Millis
Norfolk/Wrentham
Norwood
The Yankee Express
About Us
Contact Us
Advertise
Latest Issue
Archives
News
Arts & Education
Food & Entertainment
Healthy Living
Real Estate
Calendar of Events
Sports
Community
Community Announcements
Post a Community Announcement
Local Services
Business Spotlight
Professional Services
Submit an Event
List Your Business
Login/Join
Search
Search
News
Arts & Education
Food & Entertainment
Healthy Living
Real Estate
Calendar of Events
Sports
Community
Community Announcements
Post a Community Announcement
Local Services
Business Spotlight
Professional Services